Home » Consumer Goods » Asia Pacific Biopreservation Market

Asia Pacific Biopreservation Market

Asia Pacific Biopreservation Market By Type (Natural Preservatives, Microbial Preservatives, Chemical Preservatives); By Application (Food and Beverages, Pharmaceuticals, Cosmetics) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Asia Pacific Biopreservation Market Size 2023	USD 582.43 million
Asia Pacific Biopreservation Market, CAGR	26.31%
Asia Pacific Biopreservation Market Size 2032	USD 6,173.08 million

Market Overview

The Asia Pacific Biopreservation Market is projected to grow from USD 582.43 million in 2023 to an estimated USD 6,173.08 million by 2032, with a compound annual growth rate (CAGR) of 26.31% from 2024 to 2032. This remarkable growth is driven by increasing demand for biopreservation techniques in various sectors such as biopharmaceuticals, stem cell research, and regenerative medicine.

Key drivers of the Asia Pacific Biopreservation Market include the growing prevalence of chronic diseases, the surge in biopharmaceutical production, and the increasing need for personalized medicine. Furthermore, the adoption of innovative technologies, such as automated storage systems and improved cryopreservation methods, is reshaping the industry. The trend of outsourcing biopreservation services to third-party organizations and advancements in cell-based therapies are also expected to fuel market growth during the forecast period.

Geographically, Asia Pacific holds a significant share in the biopreservation market, driven by the increasing investment in healthcare infrastructure, research, and development. Countries like China, Japan, and India are key players in the market, showing substantial growth opportunities due to their large patient populations and rapid technological advancements. The market is characterized by the presence of prominent players such as Thermo Fisher Scientific, BioCision, and VWR International, who are focusing on expanding their product offerings and services in this high-growth region.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The Asia Pacific Biopreservation Market is projected to grow from USD 582.43 million in 2023 to USD 6,173.08 million by 2032, with a CAGR of 26.31% from 2024 to 2032.
Increasing biopharmaceutical production and the need for stem cell research and regenerative medicine are driving market growth.
Innovations like automated storage systems and advanced cryopreservation methods are reshaping the biopreservation industry, enhancing efficiency and scalability.
Growing healthcare infrastructure investments across Asia Pacific countries, including China, India, and Japan, are boosting the demand for biopreservation solutions.
The lack of standardized regulations across the region presents challenges for market players, especially in emerging economies.
There is a rising focus on eco-friendly biopreservation methods, driven by the growing demand for natural preservatives in food, beverages, and cosmetics.
Increasing outsourcing of biopreservation services to third-party organizations is helping companies scale operations and leverage specialized expertise.

Market Drivers

Rising Prevalence of Chronic Diseases and Aging Population

The increasing incidence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and neurological conditions in the Asia Pacific region is a significant driver for the biopreservation market. For instance, cardiovascular diseases (CVDs), cancer, and diabetes are the leading non-communicable diseases (NCDs) in this area, with CVD alone accounting for approximately 45% of all NCD deaths in 2019. The health loss from ischemic heart disease and lung cancer increased by 76% and 86%, respectively, between 1990 and 2010, highlighting the escalating burden of these conditions. These chronic diseases often require long-term medical care and the development of novel therapeutics, which include biologics and stem cell-based therapies. Biopreservation techniques are essential for the long-term storage and viability of biologics, cell therapies, and other critical biological materials used in the treatment of these diseases.Additionally, the region’s aging population further accelerates the demand for advanced medical treatments, as elderly individuals are more susceptible to chronic conditions. In countries like China and India, where the population is rapidly aging, there is a growing need for effective long-term storage solutions for biological materials used in treatments. This demographic shift not only increases the incidence of chronic diseases but also intensifies the demand for advanced medical treatments and biopreservation technologies that ensure the viability of biologics and cell therapies essential for managing these conditions. As a result, the market for biopreservation is expanding to meet the healthcare needs of this growing population.

Advancements in Biopharmaceutical Production and Personalized Medicine

The rapid growth of the biopharmaceutical industry in Asia Pacific has created a demand for robust and effective biopreservation techniques. With the rise of biologics, biosimilars, and vaccines, the need to preserve biological materials safely and efficiently has become more crucial. Biopharmaceutical companies rely heavily on biopreservation methods for the long-term storage of biologics, antibodies, enzymes, and cell-based products. As personalized medicine becomes more prevalent in the region, the need for precise and reliable storage solutions has grown. Personalized medicine focuses on tailoring treatments to individual patients, often requiring the use of patient-specific biological materials, which necessitates advanced preservation methods to ensure the integrity of these materials. These advancements are driving the demand for high-quality biopreservation solutions, including cryopreservation, controlled-rate freezing, and other cutting-edge storage techniques. The development of advanced biopharmaceutical products, along with the increasing focus on personalized healthcare, directly boosts the biopreservation market as pharmaceutical and healthcare companies strive to maintain the viability of their biologic products throughout their lifecycle.

Technological Advancements in Biopreservation Methods

Continuous innovation in biopreservation technologies is a key driver propelling the market forward. In recent years, new developments in cryopreservation techniques—such as improved cryoprotectants, more efficient storage systems, and automated solutions—have significantly enhanced the quality and cost-efficiency of biopreservation. Automated storage systems and liquid nitrogen-based storage systems provide precise temperature control and allow for high-throughput storage, becoming increasingly important in research and commercial applications. Additionally, advancements in freezing technologies such as controlled-rate freezing and vitrification are helping improve survival rates of biological materials during storage. These technologies are crucial for preserving valuable materials like stem cells, blood products, vaccines, and tissues essential for research and clinical applications. With growing needs across various industries for high-quality preservation solutions, biopreservation technology providers are continuously innovating to meet evolving demands within healthcare and life sciences sectors in Asia Pacific.

Growing Investment in Healthcare Infrastructure and R&D in Emerging Markets

The Asia Pacific region is experiencing a significant boost in healthcare investments, particularly in emerging markets like China, India, and Southeast Asia. Governments and private investors are increasingly focusing on expanding healthcare infrastructure—including state-of-the-art hospitals, research centers, and biopharmaceutical manufacturing facilities. This expansion creates a need for advanced biopreservation solutions to maintain biological materials, support clinical research, and store biological samples for future use. Furthermore, increased focus on biotechnology and pharmaceutical research drives demand for effective biopreservation methods to store cell lines, tissues, and other biological specimens for experimentation and development.As these countries develop their research capabilities within healthcare sectors—especially with heavy investments in biotech research and cell therapy—the demand for biopreservation solutions that ensure stability of biological materials will surge. Additionally, growth in medical tourism within countries like Thailand and Singapore further fuels this need as medical tourists require specialized treatments supported by advanced healthcare services. Consequently, growing investment in healthcare infrastructure and research & development (R&D) will play a significant role in driving growth within the Asia Pacific biopreservation market.

Market Trends

Increased Demand for Advanced Cryopreservation Techniques

One of the most significant trends in the Asia Pacific Biopreservation Market is the growing demand for advanced cryopreservation techniques. Cryopreservation is the process of preserving cells, tissues, and other biological materials by cooling them to sub-zero temperatures. The adoption of cryopreservation is expanding rapidly due to the rise in stem cell research, regenerative medicine, and cell-based therapies. These fields rely on cryopreservation to store biological samples and therapeutic materials for extended periods without compromising their viability. For instance, significant investments are being made in countries like Japan, China, and India to enhance cryopreservation technologies. These nations are focusing on developing state-of-the-art facilities capable of storing biological materials such as stem cells and reproductive tissues for extended periods. The advancements in cryoprotectants and controlled-rate freezing systems have improved the efficiency and reliability of these processes, ensuring that biological samples maintain their viability over time.Moreover, advancements in cryoprotectants, controlled-rate freezing systems, and the use of liquid nitrogen-based storage solutions have made cryopreservation more efficient, reliable, and cost-effective. This trend is being driven by the need to maintain the integrity of valuable biological samples used in research and clinical applications. As the demand for regenerative medicine and personalized healthcare continues to rise, the adoption of advanced cryopreservation technologies is expected to further accelerate in the region, cementing its position as a key trend in the biopreservation market.

Integration of Automation and Artificial Intelligence (AI) in Biopreservation Systems

The integration of automation and artificial intelligence (AI) in biopreservation systems is revolutionizing the market. Automated systems offer significant advantages over traditional manual processes, including enhanced precision, efficiency, and scalability. In the Asia Pacific region, the growing adoption of automated storage systems and robotic cryopreservation platforms is helping to streamline the storage and management of biological samples. These systems are particularly useful in large-scale applications, such as biobanks, pharmaceutical manufacturing, and clinical research, where the need for accurate and high-throughput storage is critical. Automation reduces the risk of human error, ensures consistent storage conditions, and enables remote monitoring of storage environments. Additionally, AI is being incorporated into these systems to optimize storage conditions, predict maintenance needs, and provide real-time data analytics. AI-powered platforms can track and analyze the viability of preserved biological materials, ensuring their integrity is maintained throughout the storage period.The increasing use of automation and AI is not only improving the efficiency of biopreservation processes but also reducing costs and supporting the growing demand for biopreservation services in the Asia Pacific region.

Outsourcing of Biopreservation Services by Pharmaceutical and Biotech Companies

Another notable trend in the Asia Pacific Biopreservation Market is the increasing outsourcing of biopreservation services by pharmaceutical and biotechnology companies. As the complexity and cost of developing and manufacturing biologics, vaccines, and cell-based therapies rise, many companies are opting to outsource the biopreservation of critical biological materials to specialized service providers. This trend is particularly prevalent among small- and medium-sized biotech firms that lack the resources to establish in-house biopreservation capabilities. By outsourcing, these companies can focus on their core competencies while benefiting from the expertise and infrastructure of specialized biopreservation service providers. The Asia Pacific region is home to several third-party logistics (3PL) companies and contract research organizations (CROs) that offer biopreservation services such as sample storage, cryopreservation, and logistics management.The outsourcing trend is particularly strong in emerging markets like India and China, where the pharmaceutical and biotech sectors are expanding rapidly. This outsourcing model allows companies to scale their operations efficiently without the burden of investing in costly infrastructure, thus driving the growth of the biopreservation market in the region.

Growth of Biobanks and Regenerative Medicine Initiatives

The expansion of biobanks and regenerative medicine initiatives is another key trend shaping the Asia Pacific Biopreservation Market. Biobanks are facilities that store biological samples such as blood, tissue, and DNA for use in medical research and clinical trials. The increasing importance of biobanks in advancing personalized medicine and genomics has spurred a surge in their establishment across Asia Pacific.Countries like Japan, South Korea, and Singapore have been leading the way in building state-of-the-art biobanks that store large volumes of biological materials for use in disease research, drug development, and biomarker discovery. These biobanks rely heavily on advanced biopreservation methods to maintain the integrity of stored samples over time. Regenerative medicine—which includes stem cell therapies and tissue engineering—is another rapidly growing field in Asia Pacific that requires highly specialized biopreservation techniques to store stem cells, tissues, and other biological materials used in therapeutic applications.The increasing investments in regenerative medicine research and the need for long-term storage solutions for stem cells, tissues, and organs are driving demand for biopreservation services in the region. As both biobank infrastructure and regenerative medicine initiatives continue to expand, so too will the need for reliable cutting-edge biopreservation solutions.

Market Challenges

Regulatory and Standardization Issues

One of the key challenges facing the Asia Pacific Biopreservation Market is the lack of consistent regulatory frameworks and standards across the region. While countries such as Japan and Singapore have established stringent regulatory environments for biopharmaceuticals and biobanking, others in the region, particularly emerging markets like India and China, face challenges in aligning with international standards for biopreservation processes. The absence of standardized regulations for the storage, handling, and transportation of biological materials can lead to variations in storage conditions, quality control, and patient safety. Moreover, differences in the approval processes for biopreservation technologies and methods between countries can result in delays and complications for market players looking to operate across multiple nations. These regulatory inconsistencies hinder the adoption of best practices and make it challenging for companies to scale their operations regionally. As a result, the market faces increased complexity in maintaining the required standards for the preservation of critical biological materials, which can impact the overall growth and development of biopreservation services in the region.

High Costs and Infrastructure Limitations

Another significant challenge in the Asia Pacific Biopreservation Market is the high cost of biopreservation technologies and the limitations in infrastructure, particularly in emerging markets. Advanced biopreservation methods, such as cryopreservation and automated storage systems, require substantial investment in both technology and infrastructure. These solutions often involve expensive equipment, maintenance costs, and specialized personnel to manage the systems. For many organizations in the region, especially small and medium-sized biotech companies or healthcare institutions, the high initial capital expenditure and ongoing operational costs make it difficult to implement these technologies. Additionally, the infrastructure required for large-scale storage and transportation of biological materials, including liquid nitrogen-based systems and temperature-controlled storage facilities, is not uniformly available across all countries in Asia Pacific. This limitation in infrastructure can impede the widespread adoption of biopreservation solutions and hinder the growth potential of the market in less-developed regions. To overcome these challenges, both public and private investments in healthcare infrastructure are essential to support the expansion and sustainability of the biopreservation market.

Market Opportunities

Expansion of Biopharmaceutical and Biotechnology Industries

One of the most significant opportunities in the Asia Pacific Biopreservation Market is the rapid expansion of the biopharmaceutical and biotechnology sectors. As the demand for biologics, cell-based therapies, and personalized medicine increases, so does the need for advanced biopreservation solutions. The growing number of biotech startups and established pharmaceutical companies in countries like China, India, Japan, and South Korea presents substantial opportunities for market players offering biopreservation services. With governments in these countries investing heavily in healthcare and biotechnology infrastructure, there is a rising demand for efficient and scalable biopreservation technologies to support drug development, clinical trials, and biologics production. Additionally, the shift toward personalized medicine, which requires the preservation of patient-specific biological materials, offers significant growth potential for biopreservation solutions in the region. As the industry evolves, there will be increasing opportunities to offer innovative and high-quality biopreservation methods that align with the growing biopharmaceutical and biotech landscapes in Asia Pacific.

Growth in Regenerative Medicine and Stem Cell Research

The Asia Pacific region is witnessing a surge in regenerative medicine and stem cell research, opening up substantial market opportunities for biopreservation technologies. Stem cells and regenerative therapies, which require the preservation of tissues, cells, and other biological materials, depend heavily on reliable biopreservation methods to ensure long-term viability. Countries like Japan and South Korea are already leading in stem cell research and regenerative medicine, and as more institutions and companies in Asia Pacific invest in these fields, the demand for advanced biopreservation services is expected to increase. With the focus on cell therapies, tissue engineering, and organ regeneration, there is a strong need for cutting-edge preservation techniques that ensure the stability of critical biological materials. This growing sector presents a lucrative opportunity for biopreservation solution providers to meet the evolving demands of regenerative medicine and stem cell-based therapies across the region.

Market Segmentation Analysis

By Type

The Asia Pacific Biopreservation Market is segmented based on the type of preservatives used, which include natural, microbial, and chemical preservatives. Natural preservatives, derived from plant or animal sources, are gaining popularity due to their organic nature and minimal environmental impact, especially in the food, beverage, and cosmetics industries. These include essential oils, enzymes, and plant extracts, driven by the growing consumer demand for clean-label products. Microbial preservatives, such as lactic acid bacteria and bacteriocins, are increasingly used in the food industry to extend product shelf life while maintaining quality, thanks to their antimicrobial properties and the shift toward sustainable ingredients. Chemical preservatives like sorbates and benzoates remain prevalent in the food, beverage, and pharmaceutical industries due to their proven effectiveness in preventing spoilage, despite growing consumer and regulatory concerns about their safety. This segment continues to dominate due to the widespread use and reliability of chemical preservatives in preserving product stability.

By Application

The Asia Pacific Biopreservation Market is segmented by application across key industries, including food and beverages, pharmaceuticals, and cosmetics. In the food and beverage sector, biopreservation techniques, such as natural and microbial preservatives, are extensively used to extend shelf life, improve food safety, and retain nutritional value, with growing demand for processed and ready-to-eat foods further driving the adoption of natural preservatives. In pharmaceuticals, biopreservation is critical for maintaining the stability and potency of biopharmaceutical products like vaccines, biologics, and cell-based therapies, with rising chronic disease prevalence and the increasing use of personalized medicine in countries like Japan and India propelling demand. In the cosmetics industry, biopreservation ensures the safety and longevity of cosmetic formulations, responding to the rising consumer demand for clean, sustainable beauty products and regulatory requirements for safety and efficacy, thus driving growth in this sector.

Segments

Based on Type

Natural Preservatives
Microbial Preservatives
Chemical Preservatives

Based on Application

Food and Beverages
Pharmaceuticals
Cosmetics

Based on Region

China
India
Japan
Southeast Asia

Regional Analysis

China (35%)

China holds the largest share of the Asia Pacific Biopreservation Market, accounting for approximately 35% of the market. The country’s rapidly expanding pharmaceutical and biotechnology industries are key drivers of this growth. China is a hub for biopharmaceutical production, with increasing investments in biologics, vaccines, and stem cell research. The growing healthcare needs of its vast population are contributing to the demand for biopreservation solutions in the medical and research sectors. Additionally, the food and beverage industry in China is adopting biopreservation technologies to ensure the safety and extended shelf life of processed foods. China’s government has also been increasing investments in healthcare infrastructure and biotechnology, further boosting market demand.

India (25%)

India holds a significant portion of the market, contributing around 25% to the overall market share. The country is witnessing rapid growth in its pharmaceutical and biotechnology sectors, with a strong focus on biopharmaceuticals and personalized medicine. India’s growing population, rising healthcare expenditures, and the increasing prevalence of chronic diseases have created a robust demand for biopreservation solutions. The country’s expanding biopharmaceutical and regenerative medicine industries are contributing to the adoption of advanced biopreservation techniques. Additionally, India’s food processing industry is evolving, and as consumer demand for packaged and processed foods increases, biopreservation plays a crucial role in enhancing food safety and quality.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Thermo Fisher Scientific Inc.
Hansen Holding A/S
Kemin Industries, Inc.
DuPont de Nemours, Inc.
BioLife Solutions Inc.
Merck KGaA
Sigma-Aldrich (Merck Group)
SABIC
STEMCELL Technologies Inc.

Competitive Analysis

The Asia Pacific Biopreservation Market is highly competitive, with key players like Thermo Fisher Scientific, Merck KGaA, and BioLife Solutions leading the market due to their extensive product portfolios and advanced technologies in biopreservation. Thermo Fisher Scientific, for example, is known for its broad range of cryopreservation systems, making it a dominant player in both the pharmaceutical and biotechnology sectors. Merck KGaA and Sigma-Aldrich, with their strong presence in life sciences and biotechnology, contribute significantly through their innovative chemical preservation technologies and biopharmaceutical solutions. Emerging players such as STEMCELL Technologies and BioLife Solutions focus on stem cell and cell-based preservation, offering specialized solutions to the growing regenerative medicine market. Additionally, companies like Chr. Hansen and Kemin Industries leverage microbial and natural preservatives, capitalizing on the rising demand for sustainable and organic preservation in food and beverage applications. The market remains dynamic, with these key players consistently investing in research, development, and acquisitions to strengthen their competitive positions.

Recent Developments

In April 2024, Thermo Fisher Scientific Inc introduced the TSX Universal Series of ultra-low temperature (ULT) freezers that feature quick recovery times and tighter temperature control, aimed at improving cold storage solutions across various settings.

In August 2024, Kemin Industries, Inc. launched KEMZYME PROMACH 5, a revolutionary protease enzyme technology aimed at enhancing poultry production efficiency in South Asia. While not directly related to biopreservation, this innovation reflects Kemin’s commitment to developing solutions that improve overall animal health and performance.

Market Concentration and Characteristics

The Asia Pacific Biopreservation Market exhibits moderate concentration, with a mix of global leaders and regional players competing for market share. Major players such as Thermo Fisher Scientific, Merck KGaA, and BioLife Solutions dominate the market through their broad product portfolios, advanced technologies, and strong presence in biopharmaceuticals, biotechnology, and healthcare sectors. These companies benefit from extensive R&D capabilities, allowing them to offer innovative preservation solutions for stem cells, regenerative medicine, and biopharmaceutical products. However, the market also includes emerging players that specialize in natural and microbial preservatives, particularly in the food and beverage industries, tapping into the growing demand for organic and sustainable solutions. The market characteristics reflect a high level of technological innovation, increasing regulatory focus on safety standards, and rising demand for biopreservation solutions across sectors like pharmaceuticals, cosmetics, and food, driving competition and fostering strategic partnerships and acquisitions.

Report Coverage

The research report offers an in-depth analysis based on Type, Application and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The Asia Pacific Biopreservation Market is expected to experience robust growth, driven by the increasing demand for biologics and regenerative medicine. Advances in preservation techniques will continue to fuel this expansion across sectors.

Governments and private entities in the region are increasing investments in healthcare infrastructure, boosting the demand for advanced biopreservation solutions. This trend will significantly contribute to the market’s development.

A surge in biotechnology startups across countries like India and China will drive demand for specialized biopreservation technologies. These companies will focus on innovative preservation methods to cater to the growing need for biologics and therapies.

The introduction of AI and automation in biopreservation systems will enhance storage efficiency, reduce errors, and enable more scalable solutions. This will play a pivotal role in driving market competitiveness.

Increasing investments in stem cell research and regenerative medicine will lead to higher demand for cryopreservation and other advanced biopreservation techniques. This will be particularly notable in countries like Japan and South Korea.

The growing demand for processed and packaged foods in the region will drive the need for biopreservation solutions. Companies in the food sector will adopt natural and microbial preservatives to meet consumer preferences for organic products.

As personalized medicine becomes more prevalent, there will be a rising need for biopreservation solutions that can store patient-specific biological samples. This trend will be particularly significant in countries with advanced healthcare systems.

The lack of uniform regulations across the Asia Pacific region may create challenges for market players. However, increasing regulatory harmonization will be crucial for market expansion and ensuring the quality of preserved biological materials.

As sustainability becomes a key focus, there will be a shift towards eco-friendly biopreservation methods. Natural preservatives and green technologies will gain momentum, driven by consumer demand for safer and more environmentally conscious solutions.

Leading market players will continue to form strategic partnerships and acquisitions to expand their portfolios and reach. Collaborations between biopharmaceutical companies and service providers will help meet the evolving needs of the biopreservation market.

CHAPTER NO. 1 : INTRODUCTION 18

1.1.1. Report Description 18

Purpose of the Report 18

USP & Key Offerings 18

1.1.2. Key Benefits for Stakeholders 18

1.1.3. Target Audience 19

1.1.4. Report Scope 19

CHAPTER NO. 2 : EXECUTIVE SUMMARY 20

2.1. Biopreservation Market Snapshot 20

2.1.1. Asia Pacific Biopreservation Market, 2018 – 2032 (USD Million) 21

CHAPTER NO. 3 : BIOPRESERVATION MARKET – INDUSTRY ANALYSIS 22

3.1. Introduction 22

3.2. Market Drivers 23

3.2.1. Growing Investments in Biotechnology and Healthcare 23

3.2.2. Increasing Demand for Natural and Clean Label Products 24

3.3. Market Restraints 25

3.3.1. Lack of Consumer Awareness 25

3.4. Market Opportunities 26

3.4.1. Growing Application in Pharmaceutical and Biomedical Research 26

3.5. Porter’s Five Forces Analysis 27

3.6. Value Chain Analysis 28

3.7. Buying Criteria 29

CHAPTER NO. 4 : RAW MATERIALS ANALYSIS 30

4.1. Key Raw Materials and Suppliers 30

4.2. Key Raw Materials Price Trend 30

CHAPTER NO. 5 : MANUFACTURING COST ANALYSIS 31

5.1. Manufacturing Cost Analysis 31

5.2. Manufacturing Process 31

CHAPTER NO. 6 : ANALYSIS COMPETITIVE LANDSCAPE 32

6.1. Company Market Share Analysis – 2023 32

6.1.1. Asia Pacific Biopreservation Market: Company Market Share, by Volume, 2023 32

6.1.2. Asia Pacific Biopreservation Market: Company Market Share, by Revenue, 2023 33

6.1.3. Asia Pacific Biopreservation Market: Top 6 Company Market Share, by Revenue, 2023 33

6.1.4. Asia Pacific Biopreservation Market: Top 3 Company Market Share, by Revenue, 2023 34

6.2. Asia Pacific Biopreservation Market Company Volume Market Share, 2023 35

6.3. Asia Pacific Biopreservation Market Company Revenue Market Share, 2023 36

6.4. Company Assessment Metrics, 2023 36

6.4.1. Stars 36

6.4.2. Emerging Leaders 36

6.4.3. Pervasive Players 36

6.4.4. Participants 36

6.5. Start-ups /SMEs Assessment Metrics, 2023 36

6.5.1. Progressive Companies 36

6.5.2. Responsive Companies 36

6.5.3. Dynamic Companies 36

6.5.4. Starting Blocks 37

6.6. Strategic Developments 38

6.6.1. Acquisitions & Mergers 38

New Product Launch 38

Country Expansion 38

6.7. Key Players Product Matrix 39

CHAPTER NO. 7 : PESTEL & ADJACENT MARKET ANALYSIS 40

7.1. PESTEL 40

7.1.1. Political Factors 40

7.1.2. Economic Factors 40

7.1.3. Social Factors 40

7.1.4. Technological Factors 40

7.1.5. Environmental Factors 40

7.1.6. Legal Factors 40

7.2. Adjacent Market Analysis 40

CHAPTER NO. 8 : BIOPRESERVATION MARKET – BY TYPE SEGMENT ANALYSIS 41

8.1. Biopreservation Market Overview, by Type Segment 41

8.1.1. Biopreservation Market Revenue Share, By Type, 2023 & 2032 42

8.1.2. Biopreservation Market Attractiveness Analysis, By Type 43

8.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 43

8.1.4. Biopreservation Market Revenue, By Type, 2018, 2023, 2027 & 2032 44

8.2. Natural Preservatives 45

8.3. Microbial Preservatives 46

8.4. Chemical Preservatives 47

CHAPTER NO. 9 : BIOPRESERVATION MARKET – BY APPLICATION SEGMENT ANALYSIS 48

9.1. Biopreservation Market Overview, by Application Segment 48

9.1.1. Biopreservation Market Revenue Share, By Application, 2023 & 2032 49

9.1.2. Biopreservation Market Attractiveness Analysis, By Application 50

9.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 50

9.1.4. Biopreservation Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

9.2. Food and Beverages 52

9.3. Pharmaceuticals 53

9.4. Cosmetics 54

CHAPTER NO. 10 : BIOPRESERVATION MARKET – ASIA PACIFIC 55

10.1. Asia Pacific 55

10.1.1. Key Highlights 55

10.1.2. Asia Pacific Biopreservation Market Revenue, By Country, 2018 – 2023 (USD Million) 56

10.1.3. Asia Pacific Biopreservation Market Revenue, By Type, 2018 – 2023 (USD Million) 57

10.1.4. Asia Pacific Biopreservation Market Revenue, By Application, 2018 – 2023 (USD Million) 58

10.1. China 58

10.2. Japan 58

10.3. South Korea 58

10.4. India 58

10.5. Australia 58

10.6. Thailand 58

10.7. Indonesia 58

10.8. Vietnam 58

10.9. Malaysia 58

10.10. Philippines 58

10.11. Taiwan 58

10.12. Rest of Asia Pacific 59

CHAPTER NO. 11 : COMPANY PROFILES 60

11.1. Thermo Fisher Scientific Inc. 60

11.1.1. Company Overview 60

11.1.2. Product Portfolio 60

11.1.3. Swot Analysis 60

11.1.4. Business Strategy 61

11.1.5. Financial Overview 61

11.2. Chr. Hansen Holding A/S 62

11.3. Kemin Industries, Inc. 62

11.4. Thermo Fisher Scientific Inc. 62

11.5. DuPont de Nemours, Inc. 62

11.6. BioLife Solutions Inc. 62

11.7. Merck KGaA 62

11.8. Sigma-Aldrich (Merck Group) 62

11.9. SABIC 62

11.10. STEMCELL Technologies Inc. 62

List of Figures

FIG NO. 1. Asia Pacific Biopreservation Market Revenue, 2018 – 2032 (USD Million) 21

FIG NO. 2. Porter’s Five Forces Analysis for Asia Pacific Biopreservation Market 27

FIG NO. 3. Value Chain Analysis for Asia Pacific Biopreservation Market 28

FIG NO. 4. Raw Materials Price Trend Analysis, 2018 – 2023 30

FIG NO. 5. Manufacturing Cost Analysis 31

FIG NO. 6. Manufacturing Process 31

FIG NO. 7. Company Share Analysis, 2023 32

FIG NO. 8. Company Share Analysis, 2023 33

FIG NO. 9. Company Share Analysis, 2023 33

FIG NO. 10. Company Share Analysis, 2023 34

FIG NO. 11. Biopreservation Market – Company Volume Market Share, 2023 35

FIG NO. 12. Biopreservation Market – Company Revenue Market Share, 2023 36

FIG NO. 13. Biopreservation Market Revenue Share, By Type, 2023 & 2032 42

FIG NO. 14. Market Attractiveness Analysis, By Type 43

FIG NO. 15. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 43

FIG NO. 16. Biopreservation Market Revenue, By Type, 2018, 2023, 2027 & 2032 44

FIG NO. 17. Asia Pacific Biopreservation Market for Natural Preservatives, Revenue (USD Million) 2018 – 2032 45

FIG NO. 18. Asia Pacific Biopreservation Market for Microbial Preservatives, Revenue (USD Million) 2018 – 2032 46

FIG NO. 19. Asia Pacific Biopreservation Market for Chemical Preservatives, Revenue (USD Million) 2018 – 2032 47

FIG NO. 20. Biopreservation Market Revenue Share, By Application, 2023 & 2032 49

FIG NO. 21. Market Attractiveness Analysis, By Application 50

FIG NO. 22. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 50

FIG NO. 23. Biopreservation Market Revenue, By Application, 2018, 2023, 2027 & 2032 51

FIG NO. 24. Asia Pacific Biopreservation Market for Food and Beverages, Revenue (USD Million) 2018 – 2032 52

FIG NO. 25. Asia Pacific Biopreservation Market for Pharmaceuticals, Revenue (USD Million) 2018 – 2032 53

FIG NO. 26. Asia Pacific Biopreservation Market for Cosmetics, Revenue (USD Million) 2018 – 2032 54

FIG NO. 27. Asia Pacific Biopreservation Market Revenue, 2018 – 2032 (USD Million) 55

List of Tables

TABLE NO. 1. : Asia Pacific Biopreservation Market: Snapshot 20

TABLE NO. 2. : Drivers for the Biopreservation Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the Biopreservation Market: Impact Analysis 25

TABLE NO. 4. : Key Raw Materials & Suppliers 30

TABLE NO. 5. : Asia Pacific Biopreservation s Market Revenue, By Country, 2018 – 2023 (USD Million) 56

TABLE NO. 6. : Asia Pacific Biopreservation Market Revenue, By Country, 2024 – 2032 (USD Million) 56

TABLE NO. 7. : Asia Pacific Biopreservation Market Revenue, By Type, 2018 – 2023 (USD Million) 57

TABLE NO. 8. : Asia Pacific Biopreservation Market Revenue, By Type, 2024 – 2032 (USD Million) 57

TABLE NO. 9. : Asia Pacific Biopreservation Market Revenue, By Application, 2018 – 2023 (USD Million) 58

TABLE NO. 10. : Asia Pacific Biopreservation Market Revenue, By Application, 2024 – 2032 (USD Million) 58

Frequently Asked Questions

What is the market size of the Asia Pacific Biopreservation Market in 2023 and 2032?

The Asia Pacific Biopreservation Market is valued at USD 582.43 million in 2023 and is projected to reach USD 6,173.08 million by 2032, with a compound annual growth rate (CAGR) of 26.31% from 2024 to 2032

What are the key drivers of the Asia Pacific Biopreservation Market?

The key drivers include the rising prevalence of chronic diseases, increased biopharmaceutical production, and the growing need for personalized medicine. Technological advancements like automated storage and cryopreservation are also contributing to market growth.

Which regions are contributing the most to the growth of the biopreservation market in Asia Pacific?

Countries like China, Japan, and India are major contributors due to their large patient populations, rapid technological advancements, and increased investments in healthcare infrastructure.

What technological innovations are shaping the biopreservation market in Asia Pacific?

Technological innovations such as automated storage systems and improved cryopreservation methods are reshaping the biopreservation market, making preservation techniques more efficient and scalable.

How is outsourcing impacting the Asia Pacific Biopreservation Market?

Outsourcing biopreservation services to third-party organizations is growing, allowing companies to scale their operations and benefit from specialized expertise, further driving the market’s expansion.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$10699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –